All Posts

Valuable insights into ALDX

We have gone through the Q2 2023 financial reports to analysis each companies product revenue to see: Q2 '23 revenue Q2 '22 revenue Q2 '23 / Q2 '22 Market cap multiple Approved products Already an Elite member? See the deeper article here! Q1 '23 vs. Q2 '23 revenue comparison Number of hedge funds that hold that company in Q2 '23 This article is NOT legal, investment or tax advice. Please do your own diligence before making any investments. Article history: 8/17/23 first pos

We have gone through the Q2 2023 financial reports to analysis each companies product revenue to see:

Last updated 8/15/23 Summary: Hedge fund holdings can help you discover new investment ideas Get more stock idea and see the full list of...

SUMMARY

Tough month for APLS • 1st: safety issue surfaces for SYFOVRE ⇨ Retinal Vasculitis • Now: IZERVAY approved early ⇨ Good for AMD patients...

Big PDUFA from a big collaboration: BIIB & SAGE PDUFA - 8/5/23 - Zuranolone in MDD & PPD Collaboration since 2020… BIIB invested $1.5B in...

BIOPHARMA STOCK NEWS FLASH APLS provides SYFOVRE safety update Background: SYFOVRE approved by FDA • Feb 2023 • pegcetacoplan injection •...

Nearing 5 yrs since Reduce- It results

BIOPHARMA STOCK NEWS FLASH